1246.HK
Boill Healthcare Holdings Limited [1246.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1246.HK Stock Summary
Top 10 Correlated ETFs
1246.HK
Top 10 Correlated Stocks
1246.HK
In the News
1246.HK Financial details
Company Rating
Sell
Market Cap
387.03M
Income
-944.28M
Revenue
796.82M
Book val./share
-0.05
Cash/share
0.02
Dividend
-
Dividend %
-
Employees
63
Optionable
No
Shortable
Yes
Earnings
24 Nov 2023
P/E
-0.34
Forward P/E
-
PEG
-0.04
P/S
0.37
P/B
-1.06
P/C
16.25
P/FCF
1.9
Quick Ratio
0.03
Current Ratio
1.03
Debt / Equity
-11.79
LT Debt / Equity
11.93
-
-
EPS (TTM)
-0.69
EPS next Y
-
EPS next Q
-
EPS this Y
-15.79%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
7.78%
Revenue last 5Y
-3.67%
Revenue Q/Q
258.46%
EPS Q/Q
-97.54%
-
-
-
-
SMA20
15.38%
SMA50
200%
SMA100
172.73%
Inst Own
-
Inst Trans
-
ROA
-18%
ROE
582%
ROC
-0.17%
Gross Margin
-
Oper. Margin
-39%
Profit Margin
-123%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.048-0.475
52W High
-
52W Low
-
RSI
60.45
Rel Volume
1.06
Avg Volume
2.45M
Volume
2.59M
Perf Week
12.07%
Perf Month
400%
Perf Quarter
215.53%
Perf Half Y
209.52%
-
-
-
-
Beta
0.817
-
-
Volatility
0.01%, 0.09%
Prev Close
4.84%
Price
0.325
Change
10.17%
1246.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.46 | 0.12 | 0.19 | 0.74 | 0.26 | |
| Net income per share | -0.22 | -0.21 | -0.13 | -0.38 | -0.32 | |
| Operating cash flow per share | 0.47 | -0.04 | -0.21 | -0.09 | 0.02 | |
| Free cash flow per share | 0.44 | -0.04 | -0.21 | -0.09 | 0.02 | |
| Cash per share | 0.08 | 0.11 | 0.14 | 0.07 | 0.06 | |
| Book value per share | 0.7 | 0.45 | 0.41 | -0.01 | -0.1 | |
| Tangible book value per share | 1.31 | 0.99 | 0.85 | 0.18 | 0.01 | |
| Share holders equity per share | 0.7 | 0.45 | 0.41 | -0.01 | -0.1 | |
| Interest debt per share | 1.14 | 1.16 | 0.9 | 1.29 | 0.94 | |
| Market cap | 1.15B | 326.66M | 224.44M | 205.06M | 116.79M | |
| Enterprise value | 2.02B | 1.19B | 900.6M | 1.68B | 1.21B | |
| P/E ratio | -5.76 | -1.72 | -1.58 | -0.4 | -0.27 | |
| Price to sales ratio | 2.75 | 3.07 | 1.04 | 0.2 | 0.34 | |
| POCF ratio | 2.71 | -10.27 | -0.97 | -1.6 | 3.92 | |
| PFCF ratio | 2.86 | -8.84 | -0.97 | -1.6 | 3.92 | |
| P/B Ratio | 1.81 | 0.8 | 0.48 | -17.77 | -0.86 | |
| PTB ratio | 1.81 | 0.8 | 0.48 | -17.77 | -0.86 | |
| EV to sales | 4.82 | 11.22 | 4.16 | 1.67 | 3.47 | |
| Enterprise value over EBITDA | -22.13 | -34.86 | -27.51 | 22.84 | -6.52 | |
| EV to operating cash flow | 4.75 | -37.49 | -3.88 | -13.07 | 40.67 | |
| EV to free cash flow | 5.02 | -32.28 | -3.88 | -13.07 | 40.67 | |
| Earnings yield | -0.17 | -0.58 | -0.63 | -2.53 | -3.67 | |
| Free cash flow yield | 0.35 | -0.11 | -1.04 | -0.63 | 0.25 | |
| Debt to equity | 1.46 | 2.36 | 1.77 | -135.7 | -8.64 | |
| Debt to assets | 0.36 | 0.44 | 0.22 | 0.45 | 0.48 | |
| Net debt to EBITDA | -9.51 | -25.32 | -20.65 | 20.05 | -5.89 | |
| Current ratio | 0.27 | 0.2 | 0.59 | 0.57 | 1.03 | |
| Interest coverage | -1.04 | -0.49 | -0.29 | 0.37 | -1.83 | |
| Income quality | -2.13 | 0.17 | 1.63 | 11.06 | -0.13 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.19 | 0.47 | 0.31 | 0.03 | 0.06 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.05 | 0.16 | 0 | 0 | 0 | |
| Capex to revenue | -0.06 | -0.05 | 0 | 0 | 0 | |
| Capex to depreciation | -1.98 | -0.52 | -0.01 | -0.02 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.87 | 1.45 | 1.09 | 0.27 | 0.84 | |
| ROIC | -0.07 | -0.04 | -0.04 | 0.02 | -0.18 | |
| Return on tangible assets | -0.08 | -0.09 | -0.04 | -0.15 | -0.18 | |
| Graham Net | -1.36 | -1.23 | -1.83 | -1.88 | -1.38 | |
| Working capital | -938.78M | -861.68M | -1.14B | -1.06B | 40.69M | |
| Tangible asset value | 1.19B | 893.81M | 953.02M | 251.17M | 8.8M | |
| Net current asset value | -1.04B | -1.08B | -1.16B | -1.82B | -766.98M | |
| Invested capital | 1.46 | 2.36 | 1.77 | -135.7 | -8.64 | |
| Average receivables | 33.35M | 52.95M | 42.72M | 2.58M | 5.47M | |
| Average payables | 91.7M | 81.42M | 54.41M | 199.94M | 271.31M | |
| Average inventory | 299.81M | 71.34M | 619.55M | 1.2B | 1.03B | |
| Days sales outstanding | 21.13 | 280.06 | 6.47 | 0.48 | 10.08 | |
| Days payables outstanding | 137.03 | 5.08 | 198.42 | 118.88 | 261.64 | |
| Days of inventory on hand | 98.01 | 103.71 | 2.24K | 481.78 | 921.59 | |
| Receivables turnover | 17.28 | 1.3 | 56.43 | 762.79 | 36.2 | |
| Payables turnover | 2.66 | 71.85 | 1.84 | 3.07 | 1.4 | |
| Inventory turnover | 3.72 | 3.52 | 0.16 | 0.76 | 0.4 | |
| ROE | -0.31 | -0.47 | -0.31 | 44.88 | 3.16 | |
| Capex per share | -0.03 | -0.01 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.62 | 0.13 | 0.2 | 0.06 | 0.2 | |
| Net income per share | -0.01 | -0.37 | -0.07 | -0.24 | -0.01 | |
| Operating cash flow per share | -0.08 | -0.07 | 0.02 | 0.01 | -0.03 | |
| Free cash flow per share | -0.08 | -0.07 | 0.01 | 0.01 | -0.03 | |
| Cash per share | 0.11 | 0.07 | 0.05 | 0.06 | 0.02 | |
| Book value per share | 0.35 | -0.01 | -0.06 | -0.1 | -0.05 | |
| Tangible book value per share | 0.7 | 0.18 | 0.05 | 0.01 | 0.05 | |
| Share holders equity per share | 0.35 | -0.01 | -0.06 | -0.1 | -0.05 | |
| Interest debt per share | 0.8 | 1.26 | 1.16 | 0.86 | 0.63 | |
| Market cap | 244.44M | 205.06M | 176.54M | 116.79M | 137.16M | |
| Enterprise value | 1.06B | 1.68B | 1.6B | 1.21B | 939.16M | |
| P/E ratio | -6.26 | -0.1 | -0.46 | -0.09 | -4.29 | |
| Price to sales ratio | 0.29 | 1.18 | 0.65 | 1.52 | 0.5 | |
| POCF ratio | -2.37 | -2.08 | 8.61 | 12.61 | -2.92 | |
| PFCF ratio | -2.35 | -2.01 | 10.52 | 9 | -2.92 | |
| P/B Ratio | 0.52 | -17.77 | -2.33 | -0.86 | -1.95 | |
| PTB ratio | 0.52 | -17.77 | -2.33 | -0.86 | -1.95 | |
| EV to sales | 1.26 | 9.65 | 5.91 | 15.79 | 3.42 | |
| Enterprise value over EBITDA | 19.06 | 370.07 | -223.16 | -2.99 | -75.04 | |
| EV to operating cash flow | -10.29 | -16.98 | 78.29 | 130.66 | -20 | |
| EV to free cash flow | -10.22 | -16.48 | 95.63 | 93.26 | -20 | |
| Earnings yield | -0.04 | -2.48 | -0.54 | -2.84 | -0.06 | |
| Free cash flow yield | -0.43 | -0.5 | 0.1 | 0.11 | -0.34 | |
| Debt to equity | 2.06 | -135.7 | -19.7 | -8.64 | -11.79 | |
| Debt to assets | 0.28 | 0.45 | 0.48 | 0.48 | 0.58 | |
| Net debt to EBITDA | 14.68 | 324.83 | -198.6 | -2.71 | -64.08 | |
| Current ratio | 0.49 | 0.57 | 0.55 | 1.03 | 1.12 | |
| Interest coverage | 0.36 | -0.05 | -0.19 | 0 | -0.41 | |
| Income quality | 10.58 | 0.19 | -0.21 | -0.07 | 5.88 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0 | 0.05 | 0 | 0.08 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.01 | 0.03 | -0.18 | 0.4 | 0 | |
| Capex to revenue | 0 | -0.02 | -0.01 | 0.05 | 0 | |
| Capex to depreciation | -0.06 | -0.27 | -0.41 | 0 | -0.01 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.24 | 0.27 | 0.3 | 0.74 | 0.08 | |
| ROIC | 0.04 | 0 | -0.01 | -0.16 | -0.02 | |
| Return on tangible assets | 0 | -0.15 | -0.03 | -0.14 | -0.01 | |
| Graham Net | -1.52 | -1.88 | -1.78 | -1.38 | -0.79 | |
| Working capital | -1.31B | -1.06B | -1.04B | 40.69M | 74.49M | |
| Tangible asset value | 949.52M | 251.17M | 66.35M | 8.8M | 63.04M | |
| Net current asset value | -1.31B | -1.82B | -1.8B | -766.98M | -679.51M | |
| Invested capital | 2.06 | -135.7 | -19.7 | -8.64 | -11.79 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0.13 | 0.68 | 17.72 | 11.3 | 0.01 | |
| Days payables outstanding | 19.93 | 181.45 | 121.6 | 260.91 | 50.41 | |
| Days of inventory on hand | 81.86 | 735.36 | 360.13 | 919.04 | 181.04 | |
| Receivables turnover | 686.45 | 132.03 | 5.08 | 7.96 | 6.87K | |
| Payables turnover | 4.52 | 0.5 | 0.74 | 0.34 | 1.79 | |
| Inventory turnover | 1.1 | 0.12 | 0.25 | 0.1 | 0.5 | |
| ROE | -0.02 | 44.03 | 1.27 | 2.45 | 0.11 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
1246.HK Frequently Asked Questions
What is Boill Healthcare Holdings Limited stock symbol ?
Boill Healthcare Holdings Limited is a HK stock and trading under the symbol 1246.HK
What is Boill Healthcare Holdings Limited stock quote today ?
Boill Healthcare Holdings Limited stock price is $0.325 today.
Is Boill Healthcare Holdings Limited stock public?
Yes, Boill Healthcare Holdings Limited is a publicly traded company.
Company Profile
- Volume Average 2.45M
- Market Capitalization 387.03M
- Employee 63
- CEO Mr. Dongfang Qiu
- Headquarters Central,HK
- IPO Date 2013-10-16
-
Website
https://www.boillhealthcare.com.hk 
Boill Healthcare Holdings Limited, an investment holding company, undertakes contracts for foundation piling in Hong Kong and Mainland China. It operates through Property Development, Healthcare Holiday Resort Development and Operation, Foundation Piling, and Securities Investment segments. The company develops and sells properties, as well as provides property management services. It also trades and invests in securities; and offers elderly home care, healthcare, and leisure services. The company was formerly known as Ngai Shun Holdings Limited and changed its name to Boill Healthcare Holdings Limited in September 2017. Boill Healthcare Holdings Limited is headquartered in Central, Hong Kong.
